# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 217B: Amendment of regulation 306 (decision about compatibility)


In regulation 306—
(a) in paragraph (2), after “Chapter 2” insert—
“and specify whether the incompatibility is insofar as the advertisement is for publication—
(a) in Great Britain;
(b) in Northern Ireland; or
(c) in both Great Britain and Northern Ireland”;
(b) in paragraph (4)—
(i) in sub-paragraph (a), after “Chapter 2” insert—
“insofar as the advertisement is for publication—
(i) in Great Britain;
(ii) in Northern Ireland; or
(iii) in both Great Britain and Northern Ireland”;
(ii) after “no longer applies” insert “in Great Britain, Northern Ireland, or both Great Britain and Northern Ireland (as appropriate)”;
(c) in paragraph (5), after “Chapter 2” insert—
“insofar as the advertisement is for publication—
(a) in Great Britain;
(b) in Northern Ireland; or
(c) in both Great Britain and Northern Ireland”;
(d) in paragraph (7)(b), after “no longer applies” insert—
“,
and where that original notice related to both Great Britain and Northern Ireland, the new notice may be expressed to apply in relation to either of or both Great Britain and Northern Ireland”;
(e) in paragraph (8), after “the advertisement” insert—
“—
(a) in Great Britain;
(b) in Northern Ireland; or
(c) in both Great Britain and Northern Ireland”.

---
Source: https://www.legislation.gov.uk/uksi/2019/775/regulation/217B (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-217B
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.